Trial intelligence / Profile preview

ACTH effects on coagulation in primary adrenal insufficiency

NL-OMON34344Recruiting

Sponsor
Slotervaartziekenhuis
Start
Feb 2011
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Open-label trial of tetracosactide hexaacetate in Addison's disease (2 arms), sponsored by Slotervaartziekenhuis. Primary endpoints: Prothrombin fragment 1+2, Endogenous thrombin potential and 7 more. Started Feb 2011; status: recruiting.

02

Drugs

tetracosactide hexaacetate
03

Conditions

Addison's disease

Beyond the preview

Go deeper on NL-OMON34344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call